Cite Filings / REPL / 0001968582-26-001160
Feed Companies Filings Check
Sign in
144

Sale of Securities

Replimune Group, Inc. · Filed 2026-11-19 · Acc 0001968582-26-001160

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-11-19 144 Sale of Securities
  • 2026-11-18 4 Chief Medical Officer sold 16,198 shares at $21.60 ($349,877)
  • 2026-11-18 4 Chief Accounting Officer sold 2,148 shares at $21.60 ($46,397)
  • 2026-11-18 4 Chief Executive Officer sold 49,026 shares at $21.60 ($1,058,962)
  • 2026-11-18 4 Chief Financial Officer sold 14,709 shares at $21.60 ($317,714)
  • 2026-11-17 144 Sale of Securities
  • 2026-11-16 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…